BASEL, Switzerland I 11, 2025 I Novartis today announced that it has entered into an agreement to acquire Anthos Therapeutics, Inc., a Boston-based, ...

Novartis is one of the world's top pharmaceutical companies, and along with neighbours Roche, the mainstay of Switzerland's centuries-long contribution to new medicines. Headquartered in Basel ...

Joint research activities will be carried out at Novartis’ sites in Basel, Switzerland, and Dublin, Ireland, as well as at the Microsoft Research Lab in Cambridge, UK. Bain Capital has agreed to ...

with the lead indication for prevention of stroke and systemic embolism in patients with atrial fibrillationAcquisition adds a late-stage asset and is aligned with Novartis strategic focus ...

Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an inve ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

Fresh off the heels of winning the bid to host the Eurovision Song Contest in 2025, after Swiss contestant and first openly nonbinary performer Nemo won the contest last year, Basel is ready for its ...

After promoting its oncology officer Chris Boshoff to chief scientific officer last fall, Pfizer has found his successor.

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

After hours: February 7 at 7:58:23 p.m. EST ...

After hours: 7:58:23 pm GMT-5 ...